Perfil
Alexis Denis worked as a Director of Medicinal Chemistry at Mutabilis SA from 2009 to 2011.
Later, from 2016 to 2020, he worked as a Director of Discovery Division at Oncodesign SA. Prior to his work experience, he earned a doctorate degree from Université Pierre et Marie Curie.
Antiguos cargos conocidos de Alexis Denis.
Empresas | Cargo | Fin |
---|---|---|
ONCODESIGN | Corporate Officer/Principal | 01/07/2020 |
Mutabilis SA
Mutabilis SA Pharmaceuticals: MajorHealth Technology Mutabilis SA specializes in the discovery and development of anti-infective drugs. It focuses on novel therapeutic approaches for controlling severe and nosocomial infections. The firm offers antibacterial, vaccines, anti-infective agents, gram-positive & negative ant virulence lead series, specific antigens, and screening technologies for antibacterial and virulence targets. The company was founded in 2001 by Xavier Nassif and is headquartered in Romainville, France. | Chief Tech/Sci/R&D Officer | 24/12/2009 |
Formación de Alexis Denis.
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas privadas | 3 |
---|---|
Mutabilis SA
Mutabilis SA Pharmaceuticals: MajorHealth Technology Mutabilis SA specializes in the discovery and development of anti-infective drugs. It focuses on novel therapeutic approaches for controlling severe and nosocomial infections. The firm offers antibacterial, vaccines, anti-infective agents, gram-positive & negative ant virulence lead series, specific antigens, and screening technologies for antibacterial and virulence targets. The company was founded in 2001 by Xavier Nassif and is headquartered in Romainville, France. | Health Technology |
Université Pierre et Marie Curie | Consumer Services |
Oncodesign SA
Oncodesign SA BiotechnologyHealth Technology Oncodesign SA is a biopharmaceutical company, which engages in the provision of solutions for the assessment and validation of anti-cancer therapies. It also offers services in pharmacology, pharmco-imaging, bio-analysis, bio-banking, translational bio-makers, and bio-decontamination. The firm operates through the following business units: Service, Biotech, and Artificial Intelligence. The company was founded by Philippe Genne and Eric Solary on January 17, 1995 and is headquartered in Dijon, France. | Health Technology |
- Bolsa de valores
- Insiders
- Alexis Denis